Related references
Note: Only part of the references are listed.Synthesis and anticancer properties of novel hydrazone derivatives incorporating pyridine and isatin moieties
Zineddine Zebbiche et al.
ARCHIV DER PHARMAZIE (2021)
Synthesis, potential antitumor activity, cell cycle analysis, and multitarget mechanisms of novel hydrazones incorporating a 4-methylsulfonylbenzene scaffold: a molecular docking study
Alaa A-M Abdel-Aziz et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2021)
Synthesis, molecular docking and evaluation of novel sulfonyl hydrazones as anticancer agents and COX-2 inhibitors
Sevil Senkardes et al.
MOLECULAR DIVERSITY (2020)
Synthesis, cytotoxic evaluation, and molecular docking studies of novel quinazoline derivatives with benzenesulfonamide and anilide tails: Dual inhibitors of EGFR/HER2
Hamad M. Alkahtani et al.
BIOORGANIC CHEMISTRY (2020)
Exploring structure-activity relationship of S-substituted 2-mercaptoquinazolin-4(3H)-one including 4-ethylbenzenesulfonamides as human carbonic anhydrase inhibitors
Adel S. El-Azab et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2020)
Antitumor activity, multitarget mechanisms, and molecular docking studies of quinazoline derivatives based on a benzenesulfonamide scaffold: Cell cycle analysis
Adel S. El-Azab et al.
BIOORGANIC CHEMISTRY (2020)
S-substituted 2-mercaptoquinazolin-4(3H)-one and 4-ethylbenzensulfonamides act as potent and selective human carbonic anhydrase IX and XII inhibitors
Adel S. El-Azab et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2020)
Synthesis and anti-inflammatory activity of sulfonamides and carboxylates incorporating trimellitimides: Dual cyclooxygenase/carbonic anhydrase inhibitory actions
Alaa A. -M. Abdel-Aziz et al.
BIOORGANIC CHEMISTRY (2019)
Synthesis of benzensulfonamides linked to quinazoline scaffolds as novel carbonic anhydrase inhibitors
Adel S. El-Azab et al.
BIOORGANIC CHEMISTRY (2019)
Facile synthesis of simple 2-oxindole-based compounds with promising antiproliferative activity
Riham F. George
FUTURE MEDICINAL CHEMISTRY (2018)
Apoptosis: A Target for Anticancer Therapy
Claire M. Pfeffer et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Synthesis, antitumour activities and molecular docking of thiocarboxylic acid ester-based NSAID scaffolds: COX-2 inhibition and mechanistic studies
Adel S. El-Azab et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2018)
Synthesis, antitumour and antioxidant activities of novel α,β-unsaturated ketones and related heterocyclic analogues: EGFR inhibition and molecular modelling study
Walaa M. El-Husseiny et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2018)
Structural alterations based on naproxen scaffold: Synthesis, evaluation of antitumor activity and COX-2 inhibition, and molecular docking
Walaa M. El-Husseiny et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
Designing multi-targeted agents: An emerging anticancer drug discovery paradigm
Rong-geng Fu et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)
Synthesis and biological evaluation of 2-styrylquinolines as antitumour agents and EGFR kinase inhibitors: molecular docking study
Magda A. -A. El-Sayed et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2017)
Synthesis, in vitro antitumour activity, and molecular docking study of novel 2-substituted mercapto-3-(3,4,5-trimethoxybenzyl)-4(3H)-quinazolinone analogues
Adel S. El-Azab et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2017)
Synthesis, anticancer and apoptosis-inducing activities of quinazoline-isatin conjugates: epidermal growth factor receptor-tyrosine kinase assay and molecular docking studies
Adel S. El-Azab et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2017)
Discovery of Small Molecules as Multi-Toll-like Receptor Agonists with Proinflammatory and Anticancer Activities
Lei Zhang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
Cardiorespiratory fitness, physical activity and cancer mortality in men
Baruch Vainshelboim et al.
PREVENTIVE MEDICINE (2017)
Combination therapy in combating cancer
Reza Bayat Mokhtari et al.
ONCOTARGET (2017)
Synthesis, antitumor and antimicrobial activity of some new 6-methyl-3-phenyl-4(3H)-quinazolinone analogues: in silico studies
Amer M. Alanazi et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2016)
Synthesis, antitumor activity and molecular docking study of some novel 3-benzyl-4(3H)quinazolinone analogues
Ibrahim A. Al-Suwaidan et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2016)
Synthesis and potential antitumor activity of 7-(4-substituted piperazin-1-yl)-4-oxoquinolines based on ciprofloxacin and norfloxacin scaffolds: in silico studies
Alaa A. -M. Abdel-Aziz et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2016)
Design, synthesis of 2,3-disubstitued 4(3H)-quinazolinone derivatives as anti-inflammatory and analgesic agents: COX-1/2 inhibitory activities and molecular docking studies
Alaa A. -M. Abdel-Aziz et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2016)
Synthesis, anti-inflammatory, analgesic and COX-1/2 inhibition activities of anilides based on 5,5-diphenylimidazolidine-2,4-dione scaffold: Molecular docking studies
Alaa A. -M. Abdel-Aziz et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2016)
Synthesis, anti-inflammatory, analgesic, COX-1/2 inhibitory activities and molecular docking studies of substituted 2-mercapto-4(3H)-quinazolinones
Alaa A. -M. Abdel-Aziz et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2016)
Synthesis and antitumor evaluation of trimethoxyanilides based on 4(3H)-quinazolinone scaffolds
Menshawy A. Mohamed et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2016)
Rational Design, Synthesis, and Biological Evaluation of 7-Azaindole Derivatives as Potent Focused Multi-Targeted Kinase Inhibitors
Benedicte Dayde-Cazals et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
DFT and experimental (FT-IR and FT-Raman) investigation of vibrational spectroscopy and molecular docking studies of 2-(4-oxo-3-phenethyl-3,4-dihydroquinazolin-2-ylthio)-N-(3,4,5-trimethoxyphenyl) acetamide
Adel S. El-Azab et al.
JOURNAL OF MOLECULAR STRUCTURE (2016)
Kinase and BET Inhibitors Together Clamp Inhibition of PI3K Signaling and Overcome Resistance to Therapy
Elias E. Stratikopoulos et al.
CANCER CELL (2015)
Design, synthesis and biological evaluation of some novel substituted quinazolines as antitumor agents
Amer M. Alanazi et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2014)
The discovery and development of cyclooxygenase-2 inhibitors as potential anticancer therapies
Mohsen Vosooghi et al.
EXPERT OPINION ON DRUG DISCOVERY (2014)
Design, synthesis and biological evaluation of 2-mercapto-3-phenethylquinazoline bearing anilide fragments as potential antitumor agents: Molecular docking study
Ibrahim A. Al-Suwaidan et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2013)
Afatinib: First Global Approval
Rosselle T. Dungo et al.
DRUGS (2013)
Synthesis, molecular modeling study, preliminary antibacterial, and antitumor evaluation of N-substituted naphthalimides and their structural analogues
Adel S. El-Azab et al.
MEDICINAL CHEMISTRY RESEARCH (2013)
Synthesis, single-crystal, in vitro antitumor evaluation and molecular docking of 3-substitued 5,5-diphenylimidazolidine-2,4-dione derivatives
Amer M. Alanazi et al.
MEDICINAL CHEMISTRY RESEARCH (2013)
Design, synthesis and biological evaluation of some novel substituted 2-mercapto-3-phenethylquinazolines as antitumor agents
Amer M. Alanazi et al.
MEDICINAL CHEMISTRY RESEARCH (2013)
Design, synthesis, single-crystal and preliminary antitumor activity of novel arenesulfonylimidazolidin-2-ones
Alaa A-M. Abdel-Aziz et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2012)
Antitumor activity of the selective cyclooxygenase-2 inhibitor, celecoxib, on breast cancer in Vitro and in Vivo
Zhi-Jun Dai et al.
CANCER CELL INTERNATIONAL (2012)
Identification and synthesis of N′-(2-oxoindolin-3-ylidene)hydrazide derivatives against c-Met kinase
Zhongjie Liang et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2011)
Design, synthesis and antibacterial activity of fluoroquinolones containing bulky arenesulfonyl fragment: 2D-QSAR and docking study
Alaa A. -M. Abdel-Aziz et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2011)
Design and Synthesis of Novel Human Epidermal Growth Factor Receptor 2 (HER2)/Epidermal Growth Factor Receptor (EGFR) Dual Inhibitors Bearing a Pyrrolo[3,2-d]pyrimidine Scaffold
Tomoyasu Ishikawa et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Synthesis and antitumor evaluation of novel diarylsulfonylurea derivatives: Molecular modeling applications
Magda A. El-Sherbeny et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2010)
Synthesis and antitumor evaluation of novel cyclic arylsulfonylureas: ADME-T and pharmacophore prediction
Ibrahim M. El-Deeb et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2010)
COX-2 as a target for cancer chemotherapy
Nilanjan Ghosh et al.
PHARMACOLOGICAL REPORTS (2010)
Lapatinib A Review of its Use in the Treatment of HER2-Overexpressing, Trastuzumab-Refractory, Advanced or Metastatic Breast Cancer
James E. Frampton
DRUGS (2009)
Procaspase-3 Activation as an Anti-Cancer Strategy: Structure-Activity Relationship of Procaspase-Activating Compound 1 (PAC-1) and Its Cellular Co-Localization with Caspase-3
Quinn P. Peterson et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Aroyl hydrazones of 2-phenylindole-3-carbaldehydes as novel antimitotic agents
Susanne Vogel et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2008)
4-amino-6-arylamino-pyrimidine-5-carbaldehyde hydrazones as potent ErbB-2/EGFR dual kinase inhibitors
Guozhang Xu et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2008)
Safety and anti-tumor activity of sorafenib (Nexavar((R))) in combination with other anti-cancer agents: a review of clinical trials
Chris H. Takimoto et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2008)
Biological activities of hydrazone derivatives
Sevim Rollas et al.
MOLECULES (2007)
A preclinical review of sunitinib, a multitargeted receptor tyrosine kinase inhibitor with anti-angiogenic and antitumour activities
J. G. Christensen
ANNALS OF ONCOLOGY (2007)
Multitarget-directed drug design strategy: A novel molecule designed to block epidermal growth factor receptor (EGFR) and to exert proapoptotic effects
Alessandra Antonello et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
The NCI60 human tumour cell line anticancer drug screen
Robert H. Shoemaker
NATURE REVIEWS CANCER (2006)
Targeting multidrug resistance in cancer
G Szakács et al.
NATURE REVIEWS DRUG DISCOVERY (2006)
Synthesis, antimicrobial activity and molecular modeling of cobalt and nickel complexes containing the bulky ligand:: bis[N-(2,6-diisopropylphenyl)imino] acenaphthene
U El-Ayaan et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2005)
Synthesis and biological evaluation of novel 6-nitro-5-substituted aminoquinolines as local anesthetic and anti-arrhythmic agents: molecular modeling study
FE Goda et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2005)
Tyrosine kinase inhibitors in cancer therapy
S Madhusudan et al.
CLINICAL BIOCHEMISTRY (2004)
Studies leading to the identification of ZD1839 (Iressa™):: An orally active, selective epidermal growth factor receptor tyrosine kinase inhibitor targeted to the treatment of cancer
AJ Barker et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2001)
Share Paper
